COSCIENS Biopharma Inc. (CSCIF) Shareholders’ equity 2016–2025
COSCIENS Biopharma Inc. (CSCIF) shareholders’ equity at each fiscal year-end, per SEC filings.
$3.8MFY2025 · since FY2016: $6.2M → $3.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.8M | -70.8% |
| FY2024 | $13.2M | -37.4% |
| FY2023 | $21.0M | -11.7% |
| FY2022 | $23.8M | +8.6% |
| FY2021 | $21.9M | +66.0% |
| FY2020 | $13.2M | +636.4% |
| FY2019 | -$2.5M | -229.2% |
| FY2018 | $1.9M | +168.5% |
| FY2017 | -$2.8M | -144.8% |
| FY2016 | $6.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice